Recruiting NA Dehydration

New treatment option for Dehydration

Official title Hydration & Female Life Stages

ClinicalTrials.gov ID: NCT07653620

What this study is testing

What it's testing
Female life stages including premenopausal, perimenopausal, postmenopausal, are characterized by changing concentrations and patterns of hormones. The premenopause stage represents the reproductive years with normal menstrual cycles lasting between 21-35 days.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 60, women only. Healthy volunteers may be eligible.

You may be able to join if

  • Sex assigned female at birth.
  • Recreationally active (engaged in light to moderate-intensity, intermittent, or steady-state exercise at least 3 days per week for at least 30 min at...
  • Age 18-60 years, within the following life stage ranges specified below:
  • Premenopausal:
  • 18-35 years

You likely can't join if

  • Currently pregnant or breastfeeding
  • \< 6 months since giving birth (even if experiencing 2 regular menstrual cycles in a row)
  • Smoking within the last 5 years
  • History of adverse events (e.g., fainting) with blood draws
  • Participants with large amount of internal metal (e.g., spinal rod) will be excluded from the DXA scan only (Brandenton)
  • Participant has participated in a clinical trial within the past 30 days
See the full eligibility criteria
Who can join
  • Sex assigned female at birth.
  • Recreationally active (engaged in light to moderate-intensity, intermittent, or steady-state exercise at least 3 days per week for at least 30 min at a time)
  • Age 18-60 years, within the following life stage ranges specified below:
  • Premenopausal:
  • 18-35 years
  • Self-report regular spontaneous menstrual cycle length (21-35 days) for the past 2 menstrual cycles
  • Menstrual cycle length \< 7 days variation in consecutive cycles
  • Perimenopausal:
  • Perimenopause: 35-55 years
  • If tracking cycles: self reported cycle irregularity (≥7 day difference from usual cycle length) for the past 2 menstrual cycles, not due to known pathology
  • If not tracking cycles: clinician diagnosis
  • Postmenopausal:
  • Postmenopause: 45-60 years
  • If tracking cycles: ≥12 consecutive months of spontaneous amenorrhea not due to pregnancy, lactation, or pathology
  • If not tracking cycles: clinician diagnosis
  • Healthy, with no known renal, cardiovascular, metabolic, or endocrine disorders that affect hydration or fluid regulation.
  • Not currently taking medications known to influence fluid balance (e.g., diuretics, laxatives, weight loss agents, or other relevant medications) or the hypothalamus-pituitary-gonadal axis (e.g., ovulation induction...
  • Not receive any fertility treatments within the past 6 months
  • No hormonal contraceptives use within the past 6 months
  • If using a paraguard copper IUD, it must be inserted for ≥ 3 months (if applicable)
  • BMI ≤ 30 kg/m²
  • Are not participating in a weight loss program
  • Are not allergic to adhesives, stevia, and strawberry lime flavoring
  • Willing to avoid strenuous activity and alcohol consumption 24 hours prior to all visits
  • Willing to fast overnight (\~12 hours) prior to the medical screening
  • For visit 2 and 4:
  • Willing to fast overnight (\~12 hours)
  • Willing to consume a minimum of 2.7 L of water 24 hours prior to visits 2 and 4, then 500 mL 2 hours before the start of the visits 2 and 4
  • For visits 3 and 5:
  • Willing to restrict all fluids (\~18 hours)
  • Willing to limit fluid consumption to 1 L the morning/afternoon prior to the start of the fluid restriction
  • Willing to restrict food (\~12 hours) the day prior to each visit Willing to eat a consistent diet the day prior
  • Fluent in English (able to read, understand, and provide informed consent).
  • Willing and able to provide informed consent to participate in the study and comply with all study procedures and scheduled visits
What rules you out
  • Currently pregnant or breastfeeding
  • \< 6 months since giving birth (even if experiencing 2 regular menstrual cycles in a row)
  • Smoking within the last 5 years
  • History of adverse events (e.g., fainting) with blood draws
  • Participants with large amount of internal metal (e.g., spinal rod) will be excluded from the DXA scan only (Brandenton)
  • Participant has participated in a clinical trial within the past 30 days
  • Participant has participated in any PepsiCo trial within past 3 months
  • Participant has a condition or is taking medication that the investigator believes would interfere with his/her ability to provide informed consent, comply with the study protocol, which might confound the...
  • Participant is employed by, or has a parent, guardian, or other immediate family member employed by a company that manufactures any products that compete with any Gatorade product. If participant is unsure if a company...

The study team makes the final eligibility decision.

Where it's taking place

  • Bradenton, Florida, United States
  • Valhalla, New York, United States

Compensation & support

Compensation mentioned.

ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.

Questions & answers

Do participants get paid in this trial?

This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling female, 18 years to 60 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Bradenton, Florida, United States; Valhalla, New York, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.